Series D funding round for Alder Biopharmaceuticals raising $38M in April 2012
Series D funding round for Alder Biopharmaceuticals raising $38M in April 2012
| Investor | Firm Type | Partner |
|---|
Novo VenturesLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$118M
Top Valuation
-
Alder Biopharmaceuticals raised $38M in a Series D round.
The round was announced on 04/01/12.
The round was led by Peter Bisgaard.